Exhaled nitric oxide (eNO) and acidity of exhaled breath condensate (EBC pH) of children with asthma, cystic fibrosis (CF) and healthy controls Source: Eur Respir J 2005; 26: Suppl. 49, 42s Year: 2005
Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma Source: Annual Congress 2007 - Assessing asthma severity and control in children Year: 2007
Oxidative stress in children with OSAS: 8-isoprostane values comparison in urine and exhaled breath condensate (EBC) Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II Year: 2015
Plasma asymmetric dimethylarginine (ADMA) in pediatric patients with cystic fibrosis (CF) Source: International Congress 2016 – Systemic biomarkers Year: 2016
Asymmetric dimethylarginine (ADMA) in EBC of asthmatic children Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy Year: 2012
Relationships between the concentrations of NO, IL1β, TNF-α, IL-6 in exhaled breath condensate (EBC) and lung function in patient with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
The 3-nitrothyrozine and total nitrate/nitrite (TNN) levels in exhaled breath condensate (EBC) in patients with bronchial asthma (BA) Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006
Inflammatory cytokines in exhaled breath condensate (EBC) of exacerbated COPD patients Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008
Cytokines in exhaled breath condensate of children with asthma and cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 468s Year: 2004
8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Expression of iNOS, exhaled NO and nitrate/nitrites in exhaled condensate in infants and toddlers with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 231s Year: 2003
Prospective nitrite, nitrate and cys-leukotriene (cys-LTs ) measurements in EBC (exhaled breath condensate) in asthmatic children and relation to outcome during inhaled steroid (IS) reduction Source: Eur Respir J 2003; 22: Suppl. 45, 534s Year: 2003
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Nitrite/nitrate in exhaled breath condensate (EBC) of patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 671s Year: 2006
Increased lactate concentrations in exhaled breath condensate (EBC) in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Nitric oxide metabolites (NOx) in exhaled breath condensate as a non-invasive marker of airway inflammation in infants with cystic fibrosis. Comparisons with bronchoalveolar lavage findings Source: Eur Respir J 2004; 24: Suppl. 48, 157s Year: 2004
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Exhaled breath condensate: 8-isoprostane and eicosanoids Source: Eur Respir Monogr 2010; 49: 196-206 Year: 2010